ST-002 (Santo Therapeutics)

N/A

Report date: 2026/04/30 20:00:20

Base Information

Drug NameST-002 (Santo Therapeutics)
Drug Alias NameST-002ST002ST-002 (Santo Therapeutics)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vectorCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeurofibromatosis 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSanto Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSanto Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsNeurofibromatosis 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A